A Trial to Assess the Efficacy and Safety of Obinutuzumab in Treating Adults With Minimal Change Disease (MCD)
A Trial to Assess the Efficacy and Safety of Obinutuzumab in Treating Adults With Minimal Change Disease (MCD)
Recruiting · NCT07710157 · Registry updated 2026-08-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial to Assess the Efficacy and Safety of Obinutuzumab in Treating Adults With Minimal Change Disease (MCD) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, minimal change disease, nephrosis, urinary system disorder | Recruiting | Phase 2 | 2026-08-17 | NCT07710157 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| 6. Medizinische Abteilung mit Nephrologie & Dialyse, Klinik Ottakring | Vienna | Austria | 1 |
| Department of Internal Medicine IV, Nephrology and Hypertension | Innsbruck | Austria | 1 |
| Division of Nephrology, Department of Internal Medicine, Medical University of Graz | Graz | Austria | 1 |
| Hôpital Henri-Mondor | Paris | France | 1 |
| Laboratory of Immunology, Nice University Hospital (CHU de Nice), Côte d'Azur University | Nice | France | 1 |
| Robert Bosch Krankenhaus, Department of General Internal Medicine and Nephrology | Stuttgart | Germany | 1 |